This study also indicates that visASCs could be implicated in the pathogenesis of metabolic syndrome since we confirmed that the deterioration in the metabolic profile of the subjects was accompanied by decreased expression levels of SOD2 as well as increased expression levels of NADPH oxidase enzymes and inflammatory cytokines in hypox-visASCs. The gene discussed is FMO5; the disease is metabolic syndrome.